baber/WOPTO huggingface dataset:
Patent FI-924651-A0 (FI)
Inventor: SEDELMEIER GOTTFRIED
IPC: C07C43/23
Filed: 1992-10-14
Abstract: Compounds of the formula I 
<IMAGE>
 in which R4 is lower alkyl and R1 is either hydroxyl, halogen, a group of the formula -P(=O)(R5)R6 (Ia), a group of the formula -P<+)<R7)(R8)R9X <-> (Ib) or a group of the formula -Si(R7)(R8)R9 (Ic), M is methylene, R2 is hydrogen or a group of the formula 
<IMAGE>
 and R3 is hydrogen or halogen or R1 is hydroxyl or lower alkoxy, M is carbonyl, R2 is hydrogen and R3 is halogen, R5 and R6 in each case independently of one another represent lower alkyl, lower alkoxy, N,N-di-lower alkylamino or benzyl, benzyloxy, phenyl or phenoxy, each of which is unsubstituted or mono- or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, R7, R8 and R9 in each case independently of one another represent lower alkyl, unsubstituted or mono- or disubstituted phenyl, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, or represent furyl, X<-> is the anion of a hydrohalic acid, a lower alkane-sulphonic acid, a halo-lower alkanesulphonic acid or a benzenesulphonic acid which is unsubstituted or monosubstituted by lower alkyl or halogen and in which Y either represents a direct bond and R10 is lower alkyl, allyl, cyano, lower alkanesulphonyl, halo-lower alkanesulphonyl, benzyl which is unsubstituted or mono- or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, or is benzenesulphonyl which is unsubstituted or monosubstituted by lower alkyl or halogen, or in which Y is a group of the formula -(C=O)- (Ie) or a group of the formula -(C=S)- (If) and R10 is halogen, lower alkyl, halo-lower alkyl, lower alkoxy, lower alkenyloxy, phenyl-lower alkenyloxy, halo-lower alkoxy, lower alkylthio or phenyl, phenoxy, phenylthio, benzyl, benzyloxy or benzylthio, each of which is unsubstituted or mono-or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, with the proviso that in a compound I in which R1 is a group Ib in which R7, R8 and R9 in each case denote unsubstituted phenyl and X<-> is the bromide ion, M is methylene, R2 is hydrogen and R4 is methyl, R3 is other than hydrogen, and with the further proviso that in a compound I in which R1 is hydroxyl, M is methylene, R2 is hydrogen and R4 is methyl or ethyl, and R3 is other than hydrogen, can be used for the preparation of compounds of the formula 
<IMAGE>
 in which R3 is halogen and R4 is lower alkyl and R10 and Y have the abovementioned meanings, and their salts. They are prepared by methods known per se.
Patent FI-925936-A0 (FI)
Inventor: SAGE JEAN-MARC
IPC: C08L77/10
Filed: 1992-12-30
Abstract: A process for the manufacture of polyamides consisting essentially of the stages of: (i) reacting 10 to 90% by weight of the aliphatic and/or cycloaliphatic and/or aromatic-aliphatic diamines (c) with a lactam and/or corresponding amino acid (a) or the substantially stoichiometric combination of one or more aliphatic diamine(s) and of one or more dicarboxylic aliphatic acid(s) and with the aromatic diacid (b); and (ii) reacting the remainder of the aliphatic and/or cycloaliphatic and/or aromatic-aliphatic diamine (c) with the oligomer produced in stage (i) in one or more substages.
Patent FI-930824-A0 (FI)
Inventor: DAEUMER BERND
IPC: C04B24/26
Filed: 1993-02-24
Abstract: Aqueous polymer dispersions which contain, as dispersants, a mixture of ethylene oxide-propylene oxide copolymer, ethoxylated alkyl phenol and/or ethoxylated fatty alcohol, ethoxylated polysaccharide and optionally, as a further component, sulphuric acid half of which has been esterified by means of ethoxylated alkylphenol and/or ethoxylated fatty alcohol.
Patent FI-935363-A0 (FI)
Inventor: HEISKARI MIKA
IPC: H04B1/44
Filed: 1993-11-30
Abstract: PCT No. PCT/FI94/00533 Sec. 371 Date May 2, 1996 Sec. 102(e) Date May 2, 1996 PCT Filed Nov. 29, 1994 PCT Pub. No. WO95/15623 PCT Pub. Date Jun. 8, 1995A method for controlling a radio unit in a radio system which has at least a first radio unit and a second radio unit in which at least one of the radio units communicates on a direct mode channel. In order either to stop the entire operation of the second radio unit or to stop it from operating on the direct mode channel, the first radio unit transmits a direct mode channel leaving request message to the second radio unit on the direct mode channel, this message commanding the second radio unit to cease from communicating on one or more direct mode channels.
Patent FI-944276-A0 (FI)
Inventor: BENNETT FRANK C
IPC: C12Q1/68
Filed: 1994-09-15
Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases associated with protein kinase C. Oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding PKC. Oligonucleotides specifically hybridizable with a translation initiation site, 5'-untranslated region or 3'-untranslated region are provided. Oligonucleotides specifically hybridizable with a particular PKC isozyme or set of isozymes are also provided. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating protein kinase C expression with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to PKC are disclosed.
Patent FI-952985-A0 (FI)
Inventor: BARBERICH TIMOTHY J
IPC: C07D487/04
Filed: 1995-06-16
Abstract: Methods are disclosed utilizing optically pure R-ketorolac for the treatment of pain, including but not limited to pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for example dental pain (e.g., after periodontal surgery) and ophthalmic pain (e.g., after cataract surgery) while avoiding adverse effects which are associated with the administration of the racemic mixture of ketorolac. The optically pure R-ketorolac is also useful in treating pyrexia while avoiding the adverse effects associated with the administration of the racemic mixture of ketorolac.
Patent FI-961797-A0 (FI)
Inventor: TEAGARDEN DIRK L
IPC: A61K9/19
Filed: 1996-04-26
Abstract: PCT No. PCT/US94/09648 Sec. 371 Date Mar. 28, 1996 Sec. 102(e) Date Mar. 28, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/11683 PCT Pub. Date May 4, 1995A stable and lyophilized formulation of prostaglandin E-1 made by the process comprising a) dissolving PGE-1 in a solution of lactose and tertiary butyl alcohol wherein said tertiary butyl alcohol is present in an amount of from about 15% to about 33% volume/volume and the ratio of said lactose to PGE-1 is from about 40,000 to 1 to about 10,000 to 1 weight/weight whereby a formulation of PGE-1dispersed in lactose is formed; b) adjusting and maintaining the pH of said formulation from about 3.5 to about 6 with an organic acid buffer; c) freezing said formulation to about -50 DEG  C.; and d) drying said formulation to obtain a moisture content of less than 1% by dry weight and a tertiary butyl alcohol content of less than 3% by dry weight. Preferably, step c) includes after freezing said formulation to about -50 DEG  C., warming to about -25 DEG  C. for about 2 hours then refreezing to about 50 DEG  C. Preferably, the prostaglandin is in an amount of about 25 to 100 ppm in lactose and the pH is maintained at about 4 to 5.
Patent FI-963776-A0 (FI)
Inventor: HAEFFNER ROGER
IPC: B01D33/21
Filed: 1996-09-23
Abstract: PCT No. PCT/SE95/00306 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/25578 PCT Pub. Date Sep. 28, 1995A rotating disc filter for separating coarse phase from a liquid mixture having carrier elements and blocking means that prevent the coarse phase from falling back into the pool of incoming liquid mixture. The capacity of the filter is increased by the prevention of the coarse phase from being filtered again and thereby occupying filter area.
Patent FI-972920-A0 (FI)
Inventor: KROEZE HENDRIK JOZEF
IPC: B31D3/02
Filed: 1997-07-09
Abstract: PCT No. PCT/NL96/00011 Sec. 371 Date Aug. 28, 1997 Sec. 102(e) Date Aug. 28, 1997 PCT Filed Jan. 8, 1996 PCT Pub. No. WO96/21554 PCT Pub. Date Jul. 18, 1996A core has honeycomb-shaped cells in rows with sides adhered to each other by glue. All the glue adhering all the cells of at least one of the rows to the cells of a next of the rows is in two glue strips that are spaced from each other.
Patent FI-974187-A0 (FI)
Inventor: HARTIKAINEN JARI
IPC: H04W36/18
Filed: 1997-11-10
Abstract: The present invention relates to a method for applying diversity reception when signals of a mobile station (MS) are received via at least two separate base stations (BTS1, BTS2). A first base station controller (BSC1) is arranged to forward the signals received from a base station (BTS1) to a second base station controller (BSC2), which is arranged to apply diversity combining to forward the received signals further to a mobile switching center (MSC1, MSC2). In connection with handover, the second base station controller (BSC2) is arranged to forward the signals received from a base station (BTS2) to the first base station controller (BSC1); a connection is set up from the first base station controller (BSC1) to the mobile switching center (MSC1, MSC2); and the first base station controller (BSC1) is arranged to apply diversity combining to forward the received signals further to the mobile switching center (MSC1, MSC2).
Patent FI-974421-A0 (FI)
Inventor: DEAN RICHARD F
IPC: H04B7/04
Filed: 1997-12-05
Abstract: A linear coverage area antenna system for use within a CDMA communication system is disclosed herein. In a preferred implementation, two linear coverage area antenna structures (210', 212') are positioned in parallel and coupled to a base station (200'). Within the base station (200'), a transmitter (220') generates remote user directed spread spectrum signals, these signals being provided to the first and second linear coverage area antenna structures (210', 212') through an antenna interface. The antenna interface includes a time delay element (292) for introducing a predetermined time delay between components of the remote user directed spread spectrum signals transmitted by the first and second linear coverage area antenna structures (210', 212'), respectively. The base station (220') also further includes at least a first demodulation element (510A) for demodulating an aggregate spread spectrum signal comprised of a plurality of system user directed spread spectrum signals received by the first linear coverage area antenna structure (210') and a second demodulation element (515A) for demodulating a second aggregate spread spectrum signal comprised of a plurality of system user directed spread spectrum signals received by the second linear coverage area antenna structure (212').
Patent IL-61988-A0 (IL)
Title: Preparation of 3'-bromo-substituted deacetoxy cephalosporanic acid sulphoxide derivatives
IPC: C07F7/18
Filed: 1981-01-26
Abstract: 3 min -Bromo-substituted deacetoxycephalosporanic acid sulphoxide derivatives are prepared by silylating the carboxy group (in order to protect same) of a 3 min -unsubstituted deacetoxycephalosporanic acid sulphoxide derivative in an inert anhydrous organic solvent, and then brominating the resulting silyl ester of the deacetoxycephalosporanic acid sulphoxide in situ.
Patent IL-66539-A0 (IL)
Title: Vertically adjustable faucet spout
IPC: E03C1/04
Filed: 1982-08-13
Abstract: A vertically adjustable faucet spout includes a base formed and adapted to seat upon a sink top, escutcheon plate or the like including a downwardly-extending guide sleeve. A vertically movable post is slidably mounted in the base and sleeve for movement relative thereto. A flexible water supply conduit is connected to the post at the lower end thereof to supply water to the assembly. A spout is positioned on the upper end of the post and is seated upon the base when the post is in the fully lowered position. The spout is rotatably movable, as a unit, and is vertically adjustable. The exterior of the post has recess means thereon and there is retaining means on the base to cooperate with the recess means to position the post, and spout in a vertically raised position relative to the base. The spout is pressure balanced whereby back pressure therein caused by flow control devices on the spout will not cause undesired vertical movement thereof.
Patent IL-80241-A0 (IL)
Title: Internal drum plotter
IPC: G06K15/00
Filed: 1986-10-07
Abstract: An internal drum plotter including a laser source (10) producing a laser beam output, apparatus (14) for modulating the laser beam output to apply information content thereto, apparatus (22) for supporting laser recording material in a generally circular cylindrical configuration about a cylinder axis (20) and scanning apparatus (23) for receiving the modulated laser beam and reflecting it onto the laser recording material, the scanning apparatus (23) including a stabilized reflector (26) arranged for rotation about the cylinder axis (20) for reflecting the modulated laser beam directly onto the laser recording material, wherein the stabilized reflector (26) is insensitive to wobble in the position thereof in directions perpendicular to the cylinder axis (20).
Patent IL-87197-A0 (IL)
Title: Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
IPC: A61K31/41
Filed: 1988-07-22
Abstract: Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors. Compounds of the formula I    <IMAGE>  (I)  in which R1, R2, R3, R4, R5, R6 and X have the indicated meanings, processes for the preparation of these compounds, the use thereof as pharmaceuticals, and pharmaceutical products based on these compounds are described. In addition, precursors for the preparation of compounds of the formula I are described.
Patent IL-98997-A0 (IL)
Title: Protective clothing
IPC: A41D31/00
Filed: 1991-07-29
Abstract: PCT No. PCT/GB91/01200 Sec. 371 Date Feb. 11, 1993 Sec. 102(e) Date Feb. 11, 1993 PCT Filed Jul. 18, 1991 PCT Pub. No. WO92/02153 PCT Pub. Date Feb. 20, 1992.An article of protective clothing designed for protection against blast has a first sheet (11) of solid material backed by a second sheet (12) of pneumatic material. The physical properties and dimensions of the two sheet (11, 12) being such that an acoustic decoupling effect is provided which greatly reduces the pressure wave effect on the body of a person wearing the clothing. The first sheet (11) might by of GRP. 9 mm thick with an areal density of 20 kg/square meter and a second sheet (12) of pneumatic material having a nominal thickness of 20 mm. 94% air content and a density of 45 kg cubic meter.
Patent SE-9802406-A0 (SE)
Title: Anordning för buntläggning av ark
Inventor: CARLSSON PER-HARALD
IPC: B65H31/02
Filed: 1998-07-06
Abstract: 8 Sammandrag Uppfinningen avser en anordning (1) for buntlaggning av ark (4) av det slag som matas ut ett efter ett vdsentligen horisontellt ur en arktryckande maskin- (3), t ex en kopiator, 5 skrivare, telefaxapparat eller liknande., Anordningen innefattar ett ovre, arkstyrande don och en undre behallare (5), vilken innefattar tva atskilda och av en botten (9) jamte tva sidostycken sammanhallna, framre och bakre vaggar (7, 8), vilka divergerar relativt varandra i riktning uppat mot en ovre Opp- ning. Det arkstyrande donet innefattar en vdlvd skiva (6), vii- ken uppvisar dels en bakre kant (16) som dr lokaliserbar pa niva Over ett horisontalplan i vilket ett arks (4) frdmre kant ankommer mot densamma, dels en undre kant (17) som dr belagen eha sidan utanfOr bakvdggens (8) overdel och a andra sidan innanfor ett lodratt plan genom frontvdggens (7) Ovre kant (11) .
Patent AU-PQ673300-A0 (AU)
Title: Starch sub-types and lipid metabolism
IPC: A23L1/308
Filed: 2000-04-06
Abstract: A method is provided for regulating carbohydrate and fat metabolism is an individual which method comprises replacing a proportion of the individual's daily carbohydrate intake with resistant starch and a proportion of the individual's saturated fat intake with unsaturated fat. Also provided are compositions comprising resistant starch and unsaturated fats and methods for making and using the same
Patent AU-PR224000-A0 (AU)
Title: An apparatus (mj28)
IPC: B41J2/055
Filed: 2000-12-21
Abstract: A nozzle guard (80) for an ink jet printer printhead With an array (14) of nozzles (10) and respective ink ejection means for ejecting ink onto a substrate to be printed, wherein the nozzle guard (80) is adapted to be positioned on the printhead to inhibit damaging contact with the exterior of the array (14) of nozzles (10).
Patent FI-20002245-A0 (FI)
Inventor: KAARNAKARI MATTI
IPC: C08L23/02
Filed: 2000-10-12
Abstract: The present invention relates to an antimicrobial polyalphaolefin composition comprising polyalphaolefin and triclosan and/or paraben as antimicrobial compound(s). The composition may be used either as such in various applications, or as a starting material for producing products that should have antimicrobial properties.
Patent FI-20075575-A0 (FI)
Inventor: JALKANEN TERO
IPC: H04L69/08
Filed: 2007-08-16
Abstract: The invention relates to a method of performing signalling and media conversion in a multioperator environment. The invention comprises receiving a signalling from a first operator; detecting a second operator of the signalling; checking information of the second operator from a database; carrying out at least one conversion to the signalling from the first operator; and transmitting the signalling to the second operator.
Patent IL-100718-A0 (IL)
Title: Odor adsorbent activated charcoal
IPC: B01J20/28
Filed: 1992-01-21
Abstract: An improved foot odor adsorbent is described having about 2.5% by weight of zinc oxide impregnated onto finely divided activated charcoal. Data is presented comparing the odor-reducing ability of the improved charcoal to conventional activated charcoal, zinc oxide powder, and standard latex foam that has been vulcanized with zinc oxide. Data is also presented showing the comparative odor-reducing ability of latex foam which incorporated various amounts of the improved activated charcoal and standard foam incorporating conventional charcoal.
Patent IL-103406-A0 (IL)
Title: Reagent which is useful for cleaving and process for using this reagent
IPC: C07B35/00
Filed: 1992-10-09
Abstract: The invention relates to a reagent useful for cleavage and to a process for using this reagent. This reagent contains a phenol B, a diluent A, a halohydric or pseudohalohydric acid whose acidity is at least equal to that of formic acid. Application to peptide synthesis.
Patent IL-116176-A0 (IL)
Title: Intermediate compounds for the diastereoselective synthesis of cis-nucleoside analogues
IPC: C07B61/00
Filed: 1995-11-28
Abstract: The present invention relates to highly diastereoselective processes for production of cis-nucleosides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.
Patent IL-119549-A0 (IL)
Title: Trehalose
IPC: A23G4/00
Filed: 1993-12-22
Abstract: A method for purifying trehalose is provided. The method comprises:       (a) providing an aqueous trehalose solution; (b) concentrating the aqueous trehalose solution to crystallize trehalose; and (c) separating and collecting the crystallized crystalline trehalose hydrate.   <MATH>
Patent IL-121659-A0 (IL)
Title: Determining cPSA in a blood sample
IPC: G01N33/577
Filed: 1997-08-29
Abstract: A method for determining the complexed forms of immunologically determinable prostate specific antigen (cPSA) in a blood sample, e.g., by two-site immunometric assays, in which the blood sample is treated to render free PSA (fPSA) immunologically nondetectable. A particularly preferred immunometric assay method employs three anti-PSA antibodies: an antibody that binds to both cPSA and fPSA (anti-tPSA), a second anti-tPSA antibody which is characterized by the unique property that binding to fPSA is blocked by binding of fPSA-specific antibodies, and a third antibody which is a fPSA-specific antibody. Thus, binding of the fPSA-specific antibody to PSA in the sample allows only cPSA to be measured in the immunometric assay. Measurement of cPSA blood levels has been found to provide a method for aiding in the diagnosis and monitoring of prostate cancer that is highly sensitive and specific, and eliminates the need for a significant number of patients to undergo unnecessary prostate biopsy.
Patent IL-128630-A0 (IL)
Title: Device and method for metering a particulate substance and apparatus comprising a plurality of such devices
IPC: A61M15/00
Filed: 1997-08-14
Abstract: A method and device are disclosed for metering a predetermined amount of a particulate substance in a reliable and exact manner. The claimed invention avoids crushing or packing the material to be metered, and can be utilized with fine particulate substances with poor flow properties such as agglomerates as well as with coarser granulates. The substance to be metered is gravity-fed by a tumbling reservoir and inlet through an unbroken and uninterrupted inflow path which comprises two parts, one which is coaxial with the rotational axis, and a second which is inclined relative to the rotational axis. After passage through the inflow path, the substance enters the metering chamber which accurately and uniformly measures the desired quantity of substance, which then exits through the outflow path. The design of the device prevents inaccurate metering through overfilling or premature emptying of the metering chamber.
Patent IL-133054-A0 (IL)
Title: Peptide nucleic acid monomers and oligomers
IPC: C08G69/08
Filed: 1998-05-22
Abstract: Novel peptide nucleic acid (PNA) oligomers and their constituent monomers are disclosed. The PNA oligomers and linked PNAs form triple stranded structures with nucleic acids that show an increased specificity for thymidine in nucleic acid targets relative to naturally occurring nucleobases.</PTEXT>
Patent IL-139681-A0 (IL)
Title: Pharmaceutical compositions containing vitamin b6
IPC: A61K31/675
Filed: 1999-04-16
Abstract: Hypertension in mammalian patients, especially elderly human patients, derived from ingestion of NSAIDs or through the normal aging process is treated by administration to the patient of a vitamin B6 (or derivative) supplement. Where the patient requires the continued administration of an NSAID for pharmacological purposes, the NSAID is administered in conjunction with a vitamin B6 supplement. The invention further provides combination pharmaceutical combinations of an NSAID and a vitamin B6 supplement, e.g. orally administrable tablets or capsules, for use in treating such conditions.
Patent IL-140388-A0 (IL)
Title: Aryl phosphate derivatives of d4t having anti-hiv activity
IPC: C07H19/20
Filed: 1999-06-29
Abstract: Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent inhibitors of HIV reverse transcriptase. In a preferred aspect of the present invention, the phosphorus of the aryl phosphate group is further substituted with an amino acid residue that may be esterified or substituted, such as a methoxy alaninyl group.